# CTC Pancreatic Adenocarcinoma

> **NCT02335151** · PHASE4 · COMPLETED · sponsor: **University of Zurich** · enrollment: 86 (actual)

## Conditions studied

- Adenocarcinoma
- Circulating Tumor Cells
- Pancreatic Neoplasms

## Interventions

- **DRUG:** Desflurane

## Key facts

- **NCT ID:** NCT02335151
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2019-09
- **Final completion:** 2019-10
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2019-12-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02335151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02335151, "CTC Pancreatic Adenocarcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02335151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*